{"DataElement":{"publicId":"2467507","version":"1","preferredName":"Brain Tumor Histologic Classification Name","preferredDefinition":"Text term to represent the name of the histologic category or classification of a brain tumor.","longName":"BRAIN_TUM_HIST_NM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2188996","version":"1","preferredName":"Brain Tumor Histologic Classification","preferredDefinition":"information related to histologic category or classification of a brain tumor.","longName":"BRAI_TUMO_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206623","version":"1","preferredName":"Brain Neoplasm","preferredDefinition":"That part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube. Functions include muscle control and coordination, sensory reception and integration, speech production, memory storage, and the elaboration of thought and emotions.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12439:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FCF8-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5CB1E3F-2BA5-3FA0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2467350","version":"1","preferredName":"Primary Brain Tumor Histologic Name","preferredDefinition":"Text terms to represent names of primary brain tumor histologic diagnoses.","longName":"PRIM_BRAIN_HIST_NM","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Anaplastic Oligoastrocytoma","valueDescription":"Anaplastic oligoastrocytoma","ValueMeaning":{"publicId":"2568646","version":"1","preferredName":"Anaplastic oligoastrocytoma","longName":"2568646","preferredDefinition":"Anaplastic Oligoastrocytoma is an Oligoastrocytoma with histological features of malignancy, such as increased cellularity, nuclear atypia, pleomorphism, and increased mitotic activity. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligoastrocytoma","conceptCode":"C6959","definition":"An oligoastrocytoma characterized by the presence of increased cellularity, nuclear atypia, pleomorphism, and high mitotic activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D933-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C564A-F235-3046-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Anaplastic Oligodendroglioma","valueDescription":"Anaplastic oligodendroglioma","ValueMeaning":{"publicId":"2572933","version":"1","preferredName":"Anaplastic oligodendroglioma","longName":"2572933","preferredDefinition":"A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma","conceptCode":"C4326","definition":"A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C564A-F259-3046-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Diffuse Astrocytoma","valueDescription":"Diffuse astrocytoma","ValueMeaning":{"publicId":"2578704","version":"1","preferredName":"Diffuse astrocytoma","longName":"2578704","preferredDefinition":"A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma","conceptCode":"C7173","definition":"A low-grade (WHO grade 2) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C564A-F27D-3046-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Gliosarcoma","valueDescription":"Gliosarcoma","ValueMeaning":{"publicId":"2578705","version":"1","preferredName":"Gliosarcoma","longName":"2578705","preferredDefinition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gliosarcoma","conceptCode":"C3796","definition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C564A-F2A1-3046-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Ependymoma","valueDescription":"Ependymoma","ValueMeaning":{"publicId":"2578706","version":"1","preferredName":"Ependymoma","longName":"2578706","preferredDefinition":"Ependymoma (WHO grade II) is the most common ependymal neoplasm. It is a slow growing tumor of children and young adults and is usually located intraventricularly.  It often causes clinical symptoms by blocking CSF pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes.(Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ependymoma","conceptCode":"C3017","definition":"A WHO grade 2, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C564A-F2BC-3046-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Fibrillary Astrocytoma","valueDescription":"Fibrillary astrocytoma","ValueMeaning":{"publicId":"2578707","version":"1","preferredName":"Fibrillary astrocytoma","longName":"2578707","preferredDefinition":"The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent.  The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrillary Astrocytoma","conceptCode":"C4322","definition":"The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent.  The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0080-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C564A-F2E1-3046-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Pilocytic Astrocytoma","valueDescription":"Pilocytic astrocytoma","ValueMeaning":{"publicId":"2578708","version":"1","preferredName":"Pilocytic astrocytoma","longName":"2578708","preferredDefinition":"Pilocytic Astrocytoma, the most common glioma in children, is a WHO grade I astrocytic tumor. It is a generally well circumscribed, slowly growing, often cystic, astrocytoma. It is histologically characterized by a biphasic pattern with varying proportion of compacted bipolar cells which may have Rosenthal fibers (tapered corkscrew-shaped, brightly eosinophilic, intracytoplasmic hyaline masses) and loose textured multipolar cells with microcysts and granular bodies. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilocytic Astrocytoma","conceptCode":"C4047","definition":"A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults.  Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0081-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E8595-A5D9-369F-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Myxopapillary Ependymoma","valueDescription":"Myxopapillary ependymoma","ValueMeaning":{"publicId":"2578709","version":"1","preferredName":"Myxopapillary ependymoma","longName":"2578709","preferredDefinition":"Myxopapillary Ependymomas (WHO grade I) are slow growing gliomas which generally occur in young adults and arise almost exclusively in the conus-cauda-filum terminale region. It generally has a favorable prognosis and is characterized histologically by tumor cells arranged in a papillary manner around vascularized mucoid stromal cores. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxopapillary Ependymoma","conceptCode":"C3697","definition":"A slow growing, WHO grade I glioma which generally occurs in young adults.  It arises almost exclusively in the conus medullaris, cauda equina, and filum terminale of the spinal cord. It generally has a favorable prognosis and is characterized histologically by tumor cells arranged in a papillary manner around vascularized mucoid stromal cores. (Adapted from WHO).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0082-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E8595-A5F1-369F-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Subependymoma","valueDescription":"Subependymoma","ValueMeaning":{"publicId":"2578710","version":"1","preferredName":"Subependymoma","longName":"2578710","preferredDefinition":"Subependymoma (WHO grade I) is a benign, slow growing neoplasm which is typically attached to a ventricular wall. It is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic change. Some lesions have the histological features of both subependymoma and ependymoma. It is often detected incidentally and has a very favorable prognosis. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subependymoma","conceptCode":"C3795","definition":"A benign, slow growing neoplasm which is typically attached to a ventricular wall. It is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic change. Some lesions have the histological features of both subependymoma and ependymoma. It is often detected incidentally and has a very favorable prognosis. (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0083-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E8CA6-18C8-37D1-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Choroid Plexus Papilloma","valueDescription":"Choroid Plexus Papilloma","ValueMeaning":{"publicId":"2572938","version":"1","preferredName":"Choroid Plexus Papilloma","longName":"2572938","preferredDefinition":"Choroid Plexus Papilloma (WHO grade I) is a benign, slow growing tumor which may cause symptoms by blocking CSF pathways. Surgical resection is usually curative. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid Plexus Papilloma","conceptCode":"C3698","definition":"A benign, slow growing tumor which may cause symptoms by blocking cerebrospinal fluid pathways.  It is characterized by the presence of delicate fibrovascular connective tissue fronds covered by a single layer of epithelial cells.  Mitotic activity is extremely low.  Surgical resection is usually curative. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E8CA6-18E0-37D1-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Choroid Plexus Carcinoma","valueDescription":"Choroid plexus carcinoma","ValueMeaning":{"publicId":"2578711","version":"1","preferredName":"Choroid plexus carcinoma","longName":"2578711","preferredDefinition":"Choroid Plexus Carcinoma (WHO grade III) is a malignant Choroid Plexus Tumor which shows anaplastic features and usually invades neighboring brain structures. CSF metastases are frequent. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid Plexus Carcinoma","conceptCode":"C4715","definition":"A malignant neoplasm arising from the choroid plexus.  It shows anaplastic features and usually invades neighboring brain structures. Cerebrospinal fluid metastases are frequent. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0084-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E8CA6-18F8-37D1-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Astroblastoma","valueDescription":"Astroblastoma","ValueMeaning":{"publicId":"2578712","version":"1","preferredName":"Astroblastoma","longName":"2578712","preferredDefinition":"Astroblastoma is a rare glial neoplasm more commonly found in young adults. It is characterized by tumor cells with characteristics suggestive of an astrocytic origin (positive for GFAP), arranged perivascularly. The cells have broad, non-tapering processes radiating towards a central blood vessel. The biologic behavior of astroblastomas is variable, so no WHO grade has been established, yet. (Adapted from WHO.) NCIPDQ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Astroblastoma, MN1-Altered","conceptCode":"C4324","definition":"A rare glial neoplasm characterized by structural rearrangements of the MN1 gene at chromosome band 22q12.1. It is usually found in the cerebral hemispheres of young adults and children and predominantly affects females. Morphologically, it consists of elongated glial cells with abundant eosinophilic cytoplasm and GFAP-positive processes, arranged perivascularly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0085-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E9E57-368A-3AE3-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Gangliocytoma","valueDescription":"Gangliocytoma","ValueMeaning":{"publicId":"2578713","version":"1","preferredName":"Gangliocytoma","longName":"2578713","preferredDefinition":"Gangliocytoma (WHO grade I) and Ganglioglioma (WHO grade I or II) are well differentiated, slow growing neuroepithelial neoplasms composed of neoplastic, mature ganglion cells either alone (gangliocytoma), or in combination with neoplastic glial cells (ganglioglioma). (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gangliocytoma","conceptCode":"C6934","definition":"A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0086-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E9E57-3699-3AE3-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Ganglioglioma","valueDescription":"Ganglioglioma","ValueMeaning":{"publicId":"2578714","version":"1","preferredName":"Ganglioglioma","longName":"2578714","preferredDefinition":"Ganglioglioma (WHO grade I or II) and Gangliocytoma (WHO grade I) are well differentiated, slow growing neuroepithelial neoplasms composed of neoplastic, mature ganglion cells either alone (gangliocytoma), or in combination with neoplastic glial cells (ganglioglioma). Some Gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III (see 'Anaplastic Ganglioglioma). There are rare cases of newly diagnosed Gangliogliomas with grade IV (Glioblastoma) changes in the glial component. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ganglioglioma","conceptCode":"C3788","definition":"A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and neoplastic glial cells. Some gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III. Rare cases of newly diagnosed gangliogliomas with grade IV (glioblastoma) changes in the glial component have also been reported. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0087-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121E9E57-36A8-3AE3-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Chordoid Glioma of the Third Ventricle","valueDescription":"Chordoid glioma of the third ventricle","ValueMeaning":{"publicId":"2568647","version":"1","preferredName":"Chordoid glioma of the third ventricle","longName":"2568647","preferredDefinition":"Chordoid Glioma of the 3rd Ventricle is a rare, slow growing, glial tumor located in the third ventricle of adults. It is characterized histologically by clusters and cords of epithelioid, GFAP expressing tumor cells within a stroma with varying amounts of mucin, which typically contains a lymphoplasmacytic infiltrate. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chordoid Glioma of the Third Ventricle","conceptCode":"C6961","definition":"Chordoid Glioma of the 3rd Ventricle is a rare, slow growing, glial tumor located in the third ventricle of adults. It is characterized histologically by clusters and cords of epithelioid, GFAP expressing tumor cells within a stroma with varying amounts of mucin, which typically contains a lymphoplasmacytic infiltrate. (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D934-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121EAA13-8B29-3C8F-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Pineocytoma","valueDescription":"Pineocytoma","ValueMeaning":{"publicId":"2578715","version":"1","preferredName":"Pineocytoma","longName":"2578715","preferredDefinition":"Pineocytoma (WHO grade II) is a slow growing tumor, more common in young adults. It is composed of small, uniform, mature cells resembling pineocytes with occasional large pineocytomatous rosettes.  It may show a wide range of divergent phenotypes, including neuronal, glial, melanocytic, photoreceptor and mesenchymal differentiation. Pineocytoma generally has a relatively favorable prognosis. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineocytoma","conceptCode":"C6966","definition":"A WHO grade 1 slow growing tumor, more frequently affecting young adults. It is composed of small, uniform, mature cells resembling pineocytes with occasional large pineocytomatous rosettes. It may show a wide range of divergent phenotypes, including neuronal, glial, melanocytic, photoreceptor and mesenchymal differentiation. Pineocytoma generally has a relatively favorable prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0088-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121EAA13-8B38-3C8F-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Dysplastic Cerebellar Gangliocytoma","valueDescription":"Lhermitte-Duclos disease","ValueMeaning":{"publicId":"2578716","version":"1","preferredName":"Lhermitte-Duclos disease","longName":"2578716","preferredDefinition":"Dysplastic Gangliocytoma of the Cerebellum (WHO grade I), also called Lhermitte-Duclos disease, is a benign cerebellar mass, which occurs in young adults and is composed of dysplastic ganglion cells.  It is the major CNS manifestation of Cowden Disease, an autosomal dominant condition that causes a variety of hamartomas and neoplasms.(Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysplastic Cerebellar Gangliocytoma","conceptCode":"C8419","definition":"A benign, WHO grade I cerebellar mass, which occurs in young adults and is composed of dysplastic ganglion cells.  It is the major CNS manifestation of Cowden disease, an autosomal dominant condition that causes a variety of hamartomas and neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0089-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2009-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121EB3EF-0355-3E15-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Desmoplastic infantile astrocytoma/ganglioma","valueDescription":"Desmoplastic Infantile Astrocytoma","ValueMeaning":{"publicId":"2578717","version":"1","preferredName":"Desmoplastic Infantile Astrocytoma","longName":"2578717","preferredDefinition":"A WHO grade I large cystic tumor that occurs almost exclusively in infants, with a prominent desmoplastic stroma having a neuroepithelial population mainly of neoplastic astrocytes. They involve the superficial cerebral cortex and leptomeninges, and often attach to the dura. Although clinically they present as large tumors, they generally have a good prognosis following surgical resection. (Adapted from WHO 2000.) - 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Infantile Astrocytoma","conceptCode":"C9476","definition":"A WHO grade I large cystic tumor that occurs almost exclusively in infants, with a prominent desmoplastic stroma having a neuroepithelial population consisting mainly of neoplastic astrocytes. It involves the superficial cerebral cortex and leptomeninges, and often attaches to the dura. Although clinically it presents as large tumor, it generally has a good prognosis following surgical resection. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12202D17-F2DD-5088-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Dysembryoplastic Neuroepithelial Tumor","valueDescription":"Dysembryoplastic Neuroepithelial Tumor","ValueMeaning":{"publicId":"2578718","version":"1","preferredName":"Dysembryoplastic Neuroepithelial Tumor","longName":"2578718","preferredDefinition":"Dysembryoplastic Neuroepithelial Tumor (WHO grade I) is a benign glial-neuronal neoplasm. It is usually supratentorial, located, generally, in the cortex and occurs in children and young adults with a long-standing history of partial seizures. A histologic hallmark of this tumor is the 'specific glioneuronal element', characterized by columns, made up of bundles of axons, oriented perpendicularly to the cortical surface. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysembryoplastic Neuroepithelial Tumor","conceptCode":"C9505","definition":"A glial-neuronal neoplasm located in the cortex. It occurs in children and young adults with a long-standing history of partial seizures. A histologic hallmark of this tumor is the 'specific glioneuronal element', characterized by columns, made up of bundles of axons, oriented perpendicularly to the cortical surface. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12202D17-F2F5-5088-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Anaplastic Ganglioglioma","valueDescription":"Anaplastic ganglioglioma","ValueMeaning":{"publicId":"2572932","version":"1","preferredName":"Anaplastic ganglioglioma","longName":"2572932","preferredDefinition":"Anaplastic Ganglioglioma (WHO grade III) is a neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. These anaplastic changes in the glial component and high MIB-1 and TP53 labelling indices may indicate aggressive behavior.  However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Ganglioglioma","conceptCode":"C4717","definition":"A WHO grade III neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. The anaplastic changes in the glial component and high MIB-1 and TP53 labeling indices may indicate aggressive behavior. However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12202D17-F30D-5088-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Central Neurocytoma","valueDescription":"Central neurocytoma","ValueMeaning":{"publicId":"2578719","version":"1","preferredName":"Central neurocytoma","longName":"2578719","preferredDefinition":"Central Neurocytoma is an intraventricular neuronal neoplasm composed of uniform round cells with neuronal differentiation. It is typically located in the lateral ventricles in the region of the foramen of Monro.  It generally affects young adults and has a favorable prognosis. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Neurocytoma","conceptCode":"C3791","definition":"An intraventricular neuronal neoplasm composed of uniform round cells with neuronal differentiation. It is typically located in the lateral ventricles in the region of the foramen of Monro. It generally affects young adults and has a favorable prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12203496-EAFD-51FC-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Cerebellar Liponeurocytoma","valueDescription":"Cerebellar liponeurocytoma","ValueMeaning":{"publicId":"2578720","version":"1","preferredName":"Cerebellar liponeurocytoma","longName":"2578720","preferredDefinition":"Cerebellar Liponeurocytoma (WHO grade I or II) is a rare cerebellar neoplasm which shows advanced neuronal/neurocytic and focal lipomatous differentiation. It occurs in adults, has a low proliferative potential and has a favorable clinical prognosis. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebellar Liponeurocytoma","conceptCode":"C6905","definition":"A rare, WHO grade II cerebellar neoplasm which shows consistent neuronal, variable astrocytic and focal lipomatous differentiation. It occurs in adults, has a low proliferative potential and usually has a favorable prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12203EE4-B0AB-53B5-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Neuroblastoma","valueDescription":"Neuroblastoma","ValueMeaning":{"publicId":"2573075","version":"1","preferredName":"Neuroblastoma","longName":"2573075","preferredDefinition":"Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA80-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"KLINGERK","dateCreated":"2005-02-04","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121FBAA9-4FAB-67AD-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Paraganglioma of the filum terminale","valueDescription":"Paraganglioma of the filum terminale","ValueMeaning":{"publicId":"2568651","version":"1","preferredName":"Paraganglioma of the filum terminale","longName":"2568651","preferredDefinition":"An extra-adrenal spinal paraganglioma arising from the cauda equina.  It should not be confused with glomus coccygeum, a structure unrelated to paraganglia.  Clinically, it may be asymptomatic or present with cauda equina syndrome, lower back pain, or leg pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cauda Equina Neuroendocrine Tumor","conceptCode":"C5324","definition":"A slow-growing, well-differentiated neuroendocrine neoplasm arising from the cauda equina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D938-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12229D30-D40D-460E-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Olfactory Neuroblastoma","valueDescription":"Olfactory Neuroblastoma","ValueMeaning":{"publicId":"2578721","version":"1","preferredName":"Olfactory Neuroblastoma","longName":"2578721","preferredDefinition":"Olfactory Neuroblastomas are rare neuroectodermal tumors. They are assumed to originate from olfactory receptor cells high in the nasal cavity. Unless resected at an early stage, they carry a poor prognosis. Microscopically, their typical pattern is neuroblastic with occasional formation of rosettes, but some lesions show neuroendocrine differentiation. When this pattern dominates the histology, the diagnosis of a neuro-endocrine carcinoma may occur. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Olfactory Neuroblastoma","conceptCode":"C3789","definition":"A rare neuroectodermal tumor originating from olfactory receptor cells in the nasal cavity or paranasal sinuses. Microscopically, it is characterized by neuroblastic differentiation with occasional formation of rosettes. If the tumor is not resected at an early stage, the prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12229D30-D425-460E-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Olfactory Neuroepithelioma","valueDescription":"Olfactory neuroepithelioma","ValueMeaning":{"publicId":"2573000","version":"1","preferredName":"Olfactory neuroepithelioma","longName":"2573000","preferredDefinition":"Smell; the faculty of smell, the sensation that results when olfactory receptors in the nose are stimulated by particular chemicals in gaseous form.: A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Olfaction","conceptCode":"C17139","definition":"The faculty of smell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primitive Neuroectodermal Tumor","conceptCode":"C3716","definition":"A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA35-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concepts to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12229D30-D431-460E-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Neuroblastoma of the adrenal gland","valueDescription":"Adrenal Gland Neuroblastoma","ValueMeaning":{"publicId":"2578722","version":"1","preferredName":"Adrenal Gland Neuroblastoma","longName":"2578722","preferredDefinition":"A neuroblastoma arising from the adrenal gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Gland Neuroblastoma","conceptCode":"C4827","definition":"A neuroblastoma arising from the adrenal gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added system generated definition for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12229D30-D449-460E-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Pineal Parenchymal tumor","valueDescription":"Pineal Parenchymal Cell Neoplasm","ValueMeaning":{"publicId":"2578723","version":"1","preferredName":"Pineal Parenchymal Cell Neoplasm","longName":"2578723","preferredDefinition":"Pineal parenchymal tumors are neoplasms of the pineocyte, a cell with photosensory and neuroendocrine functions. These tumors have a wide spectrum, with tumors composed of mature elements to ones consisting of primitive, immature cells. These tumors also have differences in biological behavior and clinical outcome.  Three types are: Pineoblastoma, Pineocytoma, Pineal Parenchymal Tumor of Intermediate Differentiation (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineal Parenchymal Cell Neoplasm","conceptCode":"C6965","definition":"A neoplasm arising from the pineocyte, a cell with photosensory and neuroendocrine functions. It may be composed of mature elements or primitive, immature cells. The cellular composition determines the biological behavior and clinical outcome. Three types are recognized: pineoblastoma, pineocytoma, and pineal parenchymal tumor of intermediate differentiation (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0090-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12229D30-D461-460E-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Ependymoblastoma","valueDescription":"Ependymoblastoma","ValueMeaning":{"publicId":"2568654","version":"1","preferredName":"Ependymoblastoma","longName":"2568654","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is characterized by the presence of multilayered rosettes formation, and increased cellularity. Symptoms include increased intracranial pressure, hydrocephalus, and focal neurological signs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered","conceptCode":"C4915","definition":"An aggressive embryonal tumor with multilayered rosettes characterized by the presence of amplification of the C19MC region on chromosome 19 (19q13.42).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12229D30-D470-460E-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Desmoplastic Medulloblastoma","valueDescription":"Desmoplastic medulloblastoma","ValueMeaning":{"publicId":"2578724","version":"1","preferredName":"Desmoplastic medulloblastoma","longName":"2578724","preferredDefinition":"Desmoplastic Medulloblastoma is a variant of Medulloblastoma. Some histologic features of this lesion include nodular, reticulin-free zones ('pale islands') surrounded by densely packed, highly proliferative cells that produce a dense intercellular reticulin fiber network. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic/Nodular Medulloblastoma","conceptCode":"C4956","definition":"A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0091-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"12229D30-D488-460E-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Large Cell Medulloblastoma","valueDescription":"Large Cell Medulloblastoma","ValueMeaning":{"publicId":"2578725","version":"1","preferredName":"Large Cell Medulloblastoma","longName":"2578725","preferredDefinition":"Large Cell Medulloblastoma is a variant of Medulloblastoma (about 4% of cases). Some features of the tumor cells are large, round and/or pleomorphic nuclei with prominent nucleoli and a more abundant cytoplasm than that found in the classic medulloblastoma. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Medulloblastoma","conceptCode":"C6904","definition":"A medulloblastoma composed of large cells with prominent nucleoli and a larger amount of cytoplasm in contrast with the cells of the classic medulloblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0092-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-06B6-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Medullomyoblastoma","valueDescription":"Medullomyoblastoma","ValueMeaning":{"publicId":"2578726","version":"1","preferredName":"Medullomyoblastoma","longName":"2578726","preferredDefinition":"Medullomyoblastoma (WHO grade IV) is a rare embryonal cerebellar neoplasm with both a primitive neuroectodermal and striated muscle component. Histologically, it is a medulloblastoma with focal myogenic differentiation. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medullomyoblastoma","conceptCode":"C3706","definition":"A rare malignant embryonal neoplasm arising from the cerebellum.  It is characterized by the morphologic features of a medulloblastoma and the presence of a striated muscle component.  Its clinical behavior is similar to medulloblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0093-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-06CE-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Melanotic Medulloblastoma","valueDescription":"Melanotic medulloblastoma","ValueMeaning":{"publicId":"2568655","version":"1","preferredName":"Melanotic medulloblastoma","longName":"2568655","preferredDefinition":"Melanotic Medulloblastoma (WHO grade IV) is a rare tumor of childhood with a predominant element of small round cells closely resembling classic medulloblastoma and a minor component of melanin-forming neuroepithelial cells. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanocytic Medulloblastoma","conceptCode":"C9497","definition":"A rare malignant embryonal neoplasm characterized by the presence of small cells which resemble the cells of classic medulloblastoma and a minor population of melanin-forming neuroepithelial cells.  It usually has an unfavorable clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-06E6-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Ganglioneuroblastoma","valueDescription":"Ganglioneuroblastoma","ValueMeaning":{"publicId":"2578727","version":"1","preferredName":"Ganglioneuroblastoma","longName":"2578727","preferredDefinition":"A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ganglioneuroblastoma","conceptCode":"C3790","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, ganglion cells, and a stroma with Schwannian differentiation constituting more than fifty-percent of the tumor volume.  There are two histologic subtypes identified: ganglioneuroblastoma, intermixed and ganglioneuroblastoma, nodular.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0094-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-06FE-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Atypical Teratoid/Rhabdoid Tumor","valueDescription":"Atypical Teratoid/Rhabdoid Tumor","ValueMeaning":{"publicId":"2578728","version":"1","preferredName":"Atypical Teratoid/Rhabdoid Tumor","longName":"2578728","preferredDefinition":"Atypical teratoid/rhabdoid tumor (WHO grade IV) is a malignant embryonal CNS tumor which occurs in children and is composed of rhabdoid cells, with or without fields resembling a classical primitive neuroectodermal tumor (PNET), epithelial tissue and neoplastic mesenchyme. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Teratoid/Rhabdoid Tumor","conceptCode":"C6906","definition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0095-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-0716-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Schwannoma","valueDescription":"Schwannoma","ValueMeaning":{"publicId":"2575032","version":"1","preferredName":"Schwannoma","longName":"2575032","preferredDefinition":"A tumor of the peripheral nervous system that arises in the nerve sheath (protective covering).  It is almost always benign, but rare malignant schwannomas have been reported.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schwannoma","conceptCode":"C3269","definition":"A benign, usually encapsulated slow growing tumor composed of Schwann cells.  It affects peripheral and cranial nerves.  It recurs infrequently and only rare cases associated with malignant transformation have been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F225-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-0725-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Embryonal Carcinoma","valueDescription":"Embryonal carcinoma","ValueMeaning":{"publicId":"2567194","version":"1","preferredName":"Embryonal carcinoma","longName":"2567194","preferredDefinition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Carcinoma","conceptCode":"C3752","definition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D387-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added missing system generated definition. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-073A-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Yolk Sac Tumor","valueDescription":"Yolk Sac Tumor","ValueMeaning":{"publicId":"2566024","version":"1","preferredName":"Yolk Sac Tumor","longName":"2566024","preferredDefinition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells. It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yolk Sac Tumor","conceptCode":"C3011","definition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells.  It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEF5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-074F-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Choriocarcinoma","valueDescription":"Choriocarcinoma","ValueMeaning":{"publicId":"2574079","version":"1","preferredName":"Choriocarcinoma","longName":"2574079","preferredDefinition":"An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choriocarcinoma","conceptCode":"C2948","definition":"An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added missing system generated definition for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-075B-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Teratoma","valueDescription":"Teratoma","ValueMeaning":{"publicId":"2566025","version":"1","preferredName":"Teratoma","longName":"2566025","preferredDefinition":"A non-seminomatous germ cell tumor characterized by the presence of various tissues which correspond to the different germinal layers (endoderm, mesoderm, and ectoderm). It occurs in the testis, ovary, and extragonadal sites including central nervous system, mediastinum, lung, and stomach. According to the level of differentiation of the tissues which comprise the tumor, teratomas are classified as mature or immature. Mature teratomas are composed of well differentiated, adult-type tissues. Immature teratomas are composed of immature, fetal-type tissues. Testicular teratomas in children follow a benign clinical course. Mature ovarian teratomas without a fetal-type component have an excellent outcome. The prognosis of immature ovarian teratomas is related to the grade and stage of the tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Teratoma","conceptCode":"C3403","definition":"A non-seminomatous germ cell tumor characterized by the presence of various tissues which correspond to the different germinal layers (endoderm, mesoderm, and ectoderm). It occurs in the testis, ovary, and extragonadal sites including central nervous system, mediastinum, lung, and stomach. According to the level of differentiation of the tissues which comprise the tumor, teratomas are classified as benign (grade 0 or 1), immature (grade 2), and malignant (grade 3). Grade 0 teratomas contain only mature elements; grade 1 teratomas have a limited degree of immaturity; grade 2 teratomas have a more extensive degree of immaturity; grade 3 teratomas are composed exclusively of immature tissues. The prognosis depends on patient age, tumor size and grade, and stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEF6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added system generated definition for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-0767-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Granular Cell Tumor","valueDescription":"Granular cell tumor","ValueMeaning":{"publicId":"2578729","version":"1","preferredName":"Granular cell tumor","longName":"2578729","preferredDefinition":"Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; it usually has a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granular Cell Tumor","conceptCode":"C3474","definition":"An unusual benign or malignant neoplasm characterized by the presence of neoplastic large polygonal cells with granular, eosinophilic cytoplasm which contains abundant lysosomes. It was originally thought to be a tumor originating from muscle cells and was named granular cell myoblastoma. Subsequent studies have suggested a derivation from Schwann cells. It affects females more often than males and it usually presents as a solitary mass. A minority of patients have multiple tumors. It can arise from many anatomic sites including the posterior pituitary gland, skin, oral cavity, esophagus, stomach, heart, mediastinum, and breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0096-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-077F-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Craniopharyngioma","valueDescription":"Craniopharyngioma","ValueMeaning":{"publicId":"2578730","version":"1","preferredName":"Craniopharyngioma","longName":"2578730","preferredDefinition":"Craniopharyngiomas (WHO grade I) are benign, partly cystic, epithelial tumors of the sellar region, presumably derived from Rathke pouch epithelium. They affect mainly children and young adults. There are two clinicopathological forms: Adamantinomatous Craniopharyngioma and Papillary Craniopharyngioma. Recent studies indicate that the age distribution and, to some extent, prognosis are different between these two variants. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Craniopharyngioma","conceptCode":"C2964","definition":"A benign, partly cystic, epithelial tumor of the sellar region, presumably derived from Rathke pouch epithelium. It affects mainly children and young adults. There are two clinicopathological forms: adamantinomatous craniopharyngioma and papillary craniopharyngioma. The most significant factor associated with recurrence is the extent of surgical resection, with lesions greater than 5 cm in diameter carrying a markedly worse prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222B23D-078E-4850-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Adamantinous Craniopharyngioma","valueDescription":"Adamantinous Craniopharyngioma","ValueMeaning":{"publicId":"2578731","version":"1","preferredName":"Adamantinous Craniopharyngioma","longName":"2578731","preferredDefinition":"Adamantinomatous Craniopharyngioma consists of broad strands, cords and bridges of a multistratified squamous epithelium with peripheral palisading of nuclei. Diagnostic features include nodules of compact 'wet' keratin and dystrophic calcification. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adamantinomatous Craniopharyngioma","conceptCode":"C4726","definition":"A craniopharyngioma consisting of broad strands, cords and bridges of a multistratified squamous epithelium with peripheral palisading of nuclei. Diagnostic features include nodules of compact 'wet' keratin and dystrophic calcification. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0098-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"SBREXT","dateModified":"2007-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222C373-64B9-4AFD-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Papillary Neoplasm","valueDescription":"Papillary Neoplasm","ValueMeaning":{"publicId":"2578732","version":"1","preferredName":"Papillary Neoplasm","longName":"2578732","preferredDefinition":"(PAP-ih-lar-ee TOO-mer) A tumor shaped like a small mushroom, with its stem attached to the epithelial layer (inner lining) of an organ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Neoplasm","conceptCode":"C36031","definition":"A benign, intermediate, or malignant neoplasm characterized by the formation of papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0099-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"SBREXT","dateModified":"2007-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222C373-64D1-4AFD-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Germinoma","valueDescription":"Germinoma","ValueMeaning":{"publicId":"2578733","version":"1","preferredName":"Germinoma","longName":"2578733","preferredDefinition":"The most common type of germ cell tumor affecting the central nervous system.  It is composed of uniform cells with large vesicular nuclei, prominent nucleoli and clear cytoplasm.  Lymphocytic or lymphoplasmacytic infiltrates are usually seen admixed with the tumor cells.  Less frequently giant syncytiotrophoblastic cells are also present.  Germinomas are usually radiosensitive and they have a favorable prognosis.  - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germinoma","conceptCode":"C3753","definition":"A malignant germ cell tumor arising in the central nervous system. It is characterized by the presence of primitive, large malignant germ cells and lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222CA23-FF1F-4BED-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Gliomatosis Cerebri","valueDescription":"Gliomatosis cerebri","ValueMeaning":{"publicId":"2578735","version":"1","preferredName":"Gliomatosis cerebri","longName":"2578735","preferredDefinition":"Gliomatosis cerebri (WHO grade II) is a diffuse glial tumor which infiltrates the brain, extensively, involving more than two lobes. It is frequently bilateral and often extends to the infratentorial structures, even to the spinal cord. It is probably of astrocytic origin, although GFAP expression may be scant or absent. (Adapted form WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gliomatosis Cerebri","conceptCode":"C4318","definition":"A diffuse glial tumor which infiltrates the brain extensively, involving more than two lobes. It is frequently bilateral and often extends to the infratentorial structures, even to the spinal cord. It is probably of astrocytic origin, although GFAP expression may be scant or absent. (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222CA23-FF67-4BED-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"High Grade Astrocytoma, NOS","valueDescription":"High Grade Astrocytoma, Not otherwise specified","ValueMeaning":{"publicId":"2578736","version":"1","preferredName":"High Grade Astrocytoma, Not otherwise specified","longName":"2578736","preferredDefinition":"Not characterized in any other way.: Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.: A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Astrocytoma","conceptCode":"C60781","definition":"A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concepts to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1222DBA3-F472-4E42-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Glioblastoma Multiforme","valueDescription":"Glioblastoma","ValueMeaning":{"publicId":"2578734","version":"1","preferredName":"Glioblastoma","longName":"2578734","preferredDefinition":"A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1256D33E-3B25-1CF6-E044-0003BA3F9857","beginDate":"2006-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-26","modifiedBy":"REEVESD","dateModified":"2006-04-26","deletedIndicator":"No"},{"value":"Low grade astrocytoma NOS","valueDescription":"Low grade astrocytoma, NOS","ValueMeaning":{"publicId":"2568650","version":"1","preferredName":"Low grade astrocytoma, NOS","longName":"2568650","preferredDefinition":"Not characterized in any other way.: Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.: A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Astrocytoma","conceptCode":"C60781","definition":"A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D937-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concepts to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104B8529-EB39-12F6-E044-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"REEVESD","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Oligoastrocytoma","valueDescription":"Oligoastrocytoma","ValueMeaning":{"publicId":"2568645","version":"1","preferredName":"Oligoastrocytoma","longName":"2568645","preferredDefinition":"A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligoastrocytoma","conceptCode":"C4050","definition":"A WHO grade 2 tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104B8529-EBF9-12F6-E044-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"REEVESD","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Oligodendroglioma","valueDescription":"9450-3 Oligodendroglioma, NOS (C71._)","ValueMeaning":{"publicId":"2564982","version":"1","preferredName":"9450-3 Oligodendroglioma, NOS (C71._)","longName":"2564982","preferredDefinition":"Not characterized in any other way.: A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor of adults, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance).  It generally recurs locally, with median post-operative survival times ranging from 3 to 5 years for patients with all histological grades. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Oligodendroglioma","conceptCode":"C3288","definition":"A well-differentiated (WHO grade 2), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104B8529-EC05-12F6-E044-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"REEVESD","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Other specify","valueDescription":"Other specify","ValueMeaning":{"publicId":"2570538","version":"1","preferredName":"Other specify","longName":"2570538","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12 - reversed concept order to match the semantics of this phrase which is \"other\" with \"specify\" as a qualifier/modifier - DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104B8529-EC11-12F6-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"REEVESD","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Meningioma","valueDescription":"Meningioma","ValueMeaning":{"publicId":"2572989","version":"1","preferredName":"Meningioma","longName":"2572989","preferredDefinition":"Meningiomas (mostly WHO grade I, with some WHO grade II or III) are generally slow growing, benign tumors attached to the dura mater and are composed of neoplastic meningothelial (arachnoidal) cells. They typically occur in adults, often women. Meningiomas have a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningioma","conceptCode":"C3230","definition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade 1 tumors, and some are WHO grade 2 or 3 tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA2A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104E246D-122D-4CCE-E044-0003BA3F9857","beginDate":"2006-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"REEVESD","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Meningioma, malignant","valueDescription":"Anaplastic (Malignant) Meningioma","ValueMeaning":{"publicId":"2578436","version":"1","preferredName":"Anaplastic (Malignant) Meningioma","longName":"2578436","preferredDefinition":"A WHO grade III meningioma exhibiting histological features of frank malignancy that exceed the abnormalities present in atypical meningioma. Anaplastic meningiomas are usually fatal, with median survival of less than 2 years. (Adapted from WHO 2000.) - 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic (Malignant) Meningioma","conceptCode":"C4051","definition":"A WHO grade III meningioma characterized by the presence of malignant morphologic features, including malignant cytology and a very high mitotic index (20 or more mitoses per ten high power fields).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF71-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"ONEDATA","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104E246D-1239-4CCE-E044-0003BA3F9857","beginDate":"2006-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"REEVESD","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Supratentorial Primitive Neuroectodermal Tumor","valueDescription":"Supratentorial primitive neuroectodermal tumor","ValueMeaning":{"publicId":"2578697","version":"1","preferredName":"Supratentorial primitive neuroectodermal tumor","longName":"2578697","preferredDefinition":"A primitive and aggressive malignant neoplasm, usually arising from the cerebral hemispheres.  It is characterized by the presence of poorly differentiated or undifferentiated neuroepithelial cells.  This category includes tumors with exclusively neuronal differentiation which are termed cerebral neuroblastomas and tumors which contain ganglion cells and are termed ganglioneuroblastomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Supratentorial Embryonal Tumor, Not Otherwise Specified","conceptCode":"C6968","definition":"A central nervous system embryonal tumor, not otherwise specified arising from the supratentorial region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0076-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C27C1-7F78-28CB-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Pleomorphic Xanthoastrocytoma","valueDescription":"Pleomorphic Xanthoastrocytoma","ValueMeaning":{"publicId":"2578698","version":"1","preferredName":"Pleomorphic Xanthoastrocytoma","longName":"2578698","preferredDefinition":"Pleomorphic Xanthoastrocytoma is an astrocytic tumor with a relatively favorable prognosis (WHO grade II) and is typically encountered in children and young adults. It has a superficial location in the cerebral hemispheres and involvement of the meninges. Characteristic features include pleomorphic and lipidized cells expressing GFAP and often surrounded by a reticulin network as well as eosinophilic granular bodies. For lesions with significant mitotic activity (5 or more mitoses per 10 HPF) and/or with areas of necrosis, the designation \"pleomorphic xanthoastrocytoma with anaplastic features\" may be used. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Xanthoastrocytoma","conceptCode":"C4323","definition":"A WHO grade 2 astrocytic tumor with a relatively favorable prognosis.  It is characterized by pleomorphic and lipidized cells expressing GFAP often surrounded by a reticulin network and eosinophilic granular bodies. It presents in the superficial cerebral hemispheres and involves the meninges. It typically affects children and young adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0077-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C27C1-7F9C-28CB-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Medulloblastoma","valueDescription":"Medulloblastoma","ValueMeaning":{"publicId":"2578699","version":"1","preferredName":"Medulloblastoma","longName":"2578699","preferredDefinition":"A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0078-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C27C1-7FB7-28CB-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Pineoblastoma","valueDescription":"Pineoblastoma","ValueMeaning":{"publicId":"2578700","version":"1","preferredName":"Pineoblastoma","longName":"2578700","preferredDefinition":"Pineoblastoma (WHO grade IV) is a highly malignant, primitive embryonal neoplasm, which occurs more commonly in children. It is composed of patternless sheets of densely packed small cells with round-to-irregular nuclei and scant cytoplasm, similar to medulloblastoma and related primitive neuroectodermal tumors. A frequent complication is metastasis via cerebrospinal fluid pathways, which is often associated with a fatal outcome. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineoblastoma","conceptCode":"C9344","definition":"A poorly differentiated malignant embryonal neoplasm arising from the pineal region.  It usually occurs in children and it is characterized by the presence of small immature neuroepithelial cells.  It may follow an aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0079-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C3F06-3213-2CD5-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"No Histology available, explain","valueDescription":"No Information Available","ValueMeaning":{"publicId":"2578438","version":"1","preferredName":"No Information Available","longName":"2578438","preferredDefinition":"Information regarding the subject is unknown or inaccessible at this time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Information Available","conceptCode":"C53269","definition":"Information regarding the subject is unknown or inaccessible at this time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF73-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1084C965-BB31-269C-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2006-04-03","deletedIndicator":"No"},{"value":"Germ Cell Tumor, malignant","valueDescription":"Germ Cell Tumor","ValueMeaning":{"publicId":"2578440","version":"1","preferredName":"Germ Cell Tumor","longName":"2578440","preferredDefinition":"This is a type of germ cell tumor that consists of large round cells with vesicular nuclei.  This tumor can be found in the ovary, undescended testis, anterior mediastinum or pineal gland. - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell Tumor","conceptCode":"C3708","definition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF75-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"ONEDATA","dateModified":"2006-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1084C965-BB49-269C-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2006-04-03","deletedIndicator":"No"},{"value":"Protoplasmic Astrocytoma","valueDescription":"Protoplasmic Astrocytoma","ValueMeaning":{"publicId":"2578701","version":"1","preferredName":"Protoplasmic Astrocytoma","longName":"2578701","preferredDefinition":"Protoplasmic Astrocytoma is a rare variant of Diffuse Astrocytoma. It is predominantly composed of neoplastic astrocytes showing a small cell body with few, flaccid processes with a low content of glial filaments and scant GFAP expression. This lesion is not well defined and is considered by some authors as an occasional histopathological feature rather than a reproducibly identifiable variant. When occurring in children, this neoplasm may be difficult to separate from Pilocytic Juvenile Astrocytoma. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protoplasmic Astrocytoma","conceptCode":"C4320","definition":"A rare variant of diffuse astrocytoma. It is predominantly composed of neoplastic astrocytes showing a small cell body with few, flaccid processes with a low content of glial filaments and scant GFAP expression. This lesion is not well defined and is considered by some authors as an occasional histopathological feature rather than a reproducibly identifiable variant. When occurring in children, this neoplasm may be difficult to separate from pilocytic juvenile astrocytoma. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C3F06-322B-2CD5-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Gemistocytic Astrocytoma","valueDescription":"Gemistocytic Astrocytoma","ValueMeaning":{"publicId":"2578702","version":"1","preferredName":"Gemistocytic Astrocytoma","longName":"2578702","preferredDefinition":"Gemistocytic Astrocytoma is a rare variant of Diffuse Astrocytoma. It is characterized by the presence of a conspicuous, though variable, fraction of gemistocytic neoplastic astrocytes. Gemistocytes are round to oval astrocytes with abundant, glassy, non-fibrillary cytoplasm which appears to displace the dark, angulated nucleus to the periphery of the cell. To make the diagnosis of Gemistocytic Astrocytoma, gemistocytes should amount to more than approximately 20% of all tumor cells. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gemistocytic Astrocytoma","conceptCode":"C4321","definition":"A rare variant of diffuse astrocytoma. It is characterized by the presence of a conspicuous, though variable, fraction of gemistocytic neoplastic astrocytes. Gemistocytes are round to oval astrocytes with abundant, glassy, non-fibrillary cytoplasm which appears to displace the dark, angulated nucleus to the periphery of the cell. To make the diagnosis of gemistocytic astrocytoma, gemistocytes should amount to more than approximately 20% of all tumor cells. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C3F06-3243-2CD5-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Anaplastic Astrocytoma","valueDescription":"Anaplastic astrocytoma","ValueMeaning":{"publicId":"2572930","version":"1","preferredName":"Anaplastic astrocytoma","longName":"2572930","preferredDefinition":"A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma","conceptCode":"C9477","definition":"A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C4BED-FF56-2EC3-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Giant Cell Glioblastoma","valueDescription":"Giant Cell Glioblastoma","ValueMeaning":{"publicId":"2578703","version":"1","preferredName":"Giant Cell Glioblastoma","longName":"2578703","preferredDefinition":"A rare histological variant of Glioblastoma (WHO grade IV) with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network and a high frequency of TP53 mutations. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Glioblastoma","conceptCode":"C4325","definition":"A rare histological variant of glioblastoma with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network, and a high frequency of TP53 mutations. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C4BED-FF6E-2EC3-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Subependymal Giant Cell Astrocytoma","valueDescription":"Subependymal giant cell astrocytoma","ValueMeaning":{"publicId":"2573017","version":"1","preferredName":"Subependymal giant cell astrocytoma","longName":"2573017","preferredDefinition":"Subependymal Giant Cell Astrocytoma is a benign, slowly growing tumor (WHO grade I) typically arising in the wall of the lateral ventricles and composed of large ganglioid astrocytes. It is the most common CNS neoplasm in patients with Tuberous Sclerosis Complex and typically occurs during the first two decades of life. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subependymal Giant Cell Astrocytoma","conceptCode":"C3696","definition":"A benign, slowly growing tumor (WHO grade I) typically arising in the wall of the lateral ventricles and composed of large ganglioid astrocytes. It is the most common CNS neoplasm in patients with tuberous sclerosis complex and typically occurs during the first two decades of life. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA46-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C4BED-FF86-2EC3-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Anaplastic Ependymoma","valueDescription":"Anaplastic ependymoma","ValueMeaning":{"publicId":"2572931","version":"1","preferredName":"Anaplastic ependymoma","longName":"2572931","preferredDefinition":"Anaplastic Ependymoma (WHO grade III) is a malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. Anaplastic Ependymomas show high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Ependymoma","conceptCode":"C4049","definition":"A WHO grade 3 malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. It is characterized by high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"121C4BED-FFAB-2EC3-E044-0003BA3F9857","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","deletedIndicator":"No"},{"value":"Primary CNS Lymphoma","valueDescription":"Central Nervous System Lymphoma","ValueMeaning":{"publicId":"2573501","version":"1","preferredName":"Central Nervous System Lymphoma","longName":"2573501","preferredDefinition":"Cancer that arises in the lymphoid tissue found in the central nervous system (CNS). The CNS includes the brain and spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Lymphoma","conceptCode":"C9301","definition":"A non-Hodgkin or Hodgkin lymphoma that arises in the brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC2A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC2D2B8B-AE79-BC8B-E040-BB89AD430465","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"ONEDATA","dateModified":"2012-03-26","deletedIndicator":"No"},{"value":"Metastatic Carcinoma","valueDescription":"Metastatic Carcinoma","ValueMeaning":{"publicId":"3421654","version":"1","preferredName":"Metastatic Carcinoma","longName":"3421654","preferredDefinition":"A carcinoma which has spread from the original site of growth to another anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Carcinoma","conceptCode":"C3482","definition":"Carcinoma that has spread from its original site of growth to other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC2D2B8B-AE86-BC8B-E040-BB89AD430465","latestVersionIndicator":"Yes","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC2D2B8B-AE9F-BC8B-E040-BB89AD430465","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"ONEDATA","dateModified":"2012-03-26","deletedIndicator":"No"},{"value":"Primary CNS Lymphoma - AIDS related","valueDescription":"Acquired Immunodeficiency Syndrome Relationship Central Nervous System Lymphoma","ValueMeaning":{"publicId":"3421655","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Relationship Central Nervous System Lymphoma","longName":"3421655","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004: Related; connected or associated.: Cancer that arises in the lymphoid tissue found in the central nervous system (CNS). The CNS includes the brain and spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Central Nervous System Lymphoma","conceptCode":"C9301","definition":"A non-Hodgkin or Hodgkin lymphoma that arises in the brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC2D2B8B-AEAD-BC8B-E040-BB89AD430465","latestVersionIndicator":"Yes","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC2D2B8B-AEC6-BC8B-E040-BB89AD430465","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"ONEDATA","dateModified":"2012-03-26","deletedIndicator":"No"},{"value":"Primary CNS Lymphoma - non-AIDS","valueDescription":"Non Acquired Immunodeficiency Syndrome Central Nervous System Lymphoma","ValueMeaning":{"publicId":"3421656","version":"1","preferredName":"Non Acquired Immunodeficiency Syndrome Central Nervous System Lymphoma","longName":"3421656","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004: Cancer that arises in the lymphoid tissue found in the central nervous system (CNS). The CNS includes the brain and spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Central Nervous System Lymphoma","conceptCode":"C9301","definition":"A non-Hodgkin or Hodgkin lymphoma that arises in the brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC2D2B8B-AED4-BC8B-E040-BB89AD430465","latestVersionIndicator":"Yes","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC2D2B8B-AEED-BC8B-E040-BB89AD430465","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"ONEDATA","dateModified":"2012-03-26","deletedIndicator":"No"},{"value":"Radiation necrosis","valueDescription":"Radiation Necrosis","ValueMeaning":{"publicId":"3421658","version":"1","preferredName":"Radiation Necrosis","longName":"3421658","preferredDefinition":"Tissue necrosis due to radiation exposure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Necrosis","conceptCode":"C94479","definition":"Tissue necrosis due to radiation exposure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC2D2B8B-AEFA-BC8B-E040-BB89AD430465","latestVersionIndicator":"Yes","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC2D2B8B-AF13-BC8B-E040-BB89AD430465","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"ONEDATA","dateModified":"2012-03-26","deletedIndicator":"No"},{"value":"Pituitary Tumor","valueDescription":"Pituitary Gland Neoplasm","ValueMeaning":{"publicId":"3210722","version":"1","preferredName":"Pituitary Gland Neoplasm","longName":"3210722","preferredDefinition":"A benign or malignant neoplasm affecting the pituitary gland. The vast majority are adenomas arising from the anterior lobe of the pituitary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pituitary Gland Neoplasm","conceptCode":"C3330","definition":"A benign or malignant neoplasm affecting the pituitary gland. The vast majority are pituitary neuroendocrine tumors (formerly pituitary adenomas).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9460-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC2D2B8B-AF27-BC8B-E040-BB89AD430465","beginDate":"2012-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-26","modifiedBy":"ONEDATA","dateModified":"2012-03-26","deletedIndicator":"No"},{"value":"Anaplastic Pleomorphic Xanthoastrocytoma","valueDescription":"Anaplastic Pleomorphic Xanthoastrocytoma","ValueMeaning":{"publicId":"5525097","version":"1","preferredName":"Anaplastic Pleomorphic Xanthoastrocytoma","longName":"5525097","preferredDefinition":"A WHO grade III pleomorphic xanthoastrocytoma characterized by the presence of five or more mitoses per 10 high-power fields. Necrosis may be present. Patients have shorter survival rates when compared to those with WHO grade II pleomorphic xanthoastrocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Pleomorphic Xanthoastrocytoma","conceptCode":"C129327","definition":"A WHO grade 3 pleomorphic xanthoastrocytoma characterized by the presence of five or more mitoses per 10 high-power fields. Necrosis may be present. Patients have shorter survival rates when compared to those with WHO grade 2 pleomorphic xanthoastrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F12FE8D-C807-5079-E053-F662850A582D","latestVersionIndicator":"Yes","beginDate":"2016-10-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F12FE8D-C820-5079-E053-F662850A582D","beginDate":"2016-10-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-17","modifiedBy":"ONEDATA","dateModified":"2016-10-17","deletedIndicator":"No"},{"value":"Diffuse Midline Glioma","valueDescription":"Diffuse Midline Glioma, H3 K27M-Mutant","ValueMeaning":{"publicId":"5698570","version":"1","preferredName":"Diffuse Midline Glioma, H3 K27M-Mutant","longName":"5698570","preferredDefinition":"A childhood diffuse midline glioma characterized by the presence of histone H3 K27M mutation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Midline Glioma, H3 K27M-Mutant","conceptCode":"C129309","definition":"A diffuse midline glioma characterized by the presence of histone H3 K27M mutation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B31F-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454CC28-1017-10AB-E053-F662850A3348","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Low Grade Glioma","valueDescription":"Low Grade Glioma","ValueMeaning":{"publicId":"7315250","version":"1","preferredName":"Low Grade Glioma","longName":"7315250","preferredDefinition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Glioma","conceptCode":"C132067","definition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7098F74-26D6-7CC5-E053-4EBD850A4F07","latestVersionIndicator":"Yes","beginDate":"2020-06-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7098F74-26EF-7CC5-E053-4EBD850A4F07","beginDate":"2020-06-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-06-01","modifiedBy":"ONEDATA","dateModified":"2020-06-01","deletedIndicator":"No"},{"value":"High Grade Glioma","valueDescription":"Malignant Glioma","ValueMeaning":{"publicId":"7315251","version":"1","preferredName":"Malignant Glioma","longName":"7315251","preferredDefinition":"A malignant neuroglial neoplasm. The term can apply to several primary neoplasm of the brain and spinal cord, including astrocytoma and oligodendroglioma in addition to others.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Glioma","conceptCode":"C4822","definition":"A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7098F74-26FB-7CC5-E053-4EBD850A4F07","latestVersionIndicator":"Yes","beginDate":"2020-06-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7098F74-2716-7CC5-E053-4EBD850A4F07","beginDate":"2020-06-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-06-01","modifiedBy":"ONEDATA","dateModified":"2020-06-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"104B8512-9D23-12DC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-31","modifiedBy":"MAESKEB","dateModified":"2020-06-01","changeDescription":"Added PVs for ABTC per request by J.Zhao. mc 3/26/12 Associated concepts to VMs and added missing VM definitions for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812580","version":"1","longName":"Duke 500","context":"NCIP"},{"publicId":"2812582","version":"1","longName":"P1_CPT_BCNU_RD","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3335728","version":"1","longName":"Protocols","context":"ABTC","ClassificationSchemeItems":[{"publicId":"3335732","version":"1","longName":"ABTC 0904","context":"ABTC"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"BRAIN_TUM_HIST_NM","type":"USED_BY","context":"Alliance"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Histologic Diagnosis","type":"Preferred Question Text","description":"Histologic Diagnosis","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"If you selected 10008093, please indicate the disease subtype:","url":null,"context":"COG"},{"name":"COG CRF Text 100","type":"Alternate Question Text","description":"Disease subtype:","url":null,"context":"COG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"If SDC is 10008093, specify disease subtype:","url":null,"context":"COG"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Select histology for screening:","url":null,"context":"COG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"If you selected High Grade Astrocytic Tumor, please indicate the disease subtype:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1084E575-C366-29C4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"SPRINGERL","dateModified":"2022-02-14","changeDescription":"Approved by Duke University 4/24/2006","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}